Associations of the <i>MUC5B</i> promoter variant with timing of interstitial lung disease and rheumatoid arthritis onset
Gregory C McDermott(Brigham and Women's Hospital), Jeffrey A. Sparks(Brigham and Women's Hospital), Lauren Prisco(Brigham and Women's Hospital), Michael H. Cho(Brigham and Women's Hospital), Tracy J. Doyle(Brigham and Women's Hospital), Ritu R. Gill(Presbyterian Hospital), Suzanne Byrne(Brigham and Women's Hospital), Alessandra Zaccardelli(Brigham and Women's Hospital), Jing Cui(Shandong Agricultural University), Paul F. Dellaripa(Brigham and Women's Hospital), Vanessa L. Kronzer(Mayo Clinic), Weixing Huang(Brigham and Women's Hospital), Nancy A. Shadick(Brigham and Women's Hospital), Lily Martin(Brigham and Women's Hospital), Matthew Moll(Brigham and Women's Hospital), Staci Gagne(Brigham and Women's Hospital)
Cited by 29
Related Papers
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
|Nature Genetics|2010|1.3k
Two independent alleles at 6q23 associated with risk of rheumatoid arthritis
|Nature Genetics|2007|550
Common variants at CD40 and other loci confer risk of rheumatoid arthritis
|Nature Genetics|2008|542